Market Highlights
Increasing prevalence of neurological/brain disorder like arteriovenous malformation, epilepsy, rising need for better treatment for rare disease, increasing investment of biotechnology and pharmaceutical industries in R&D, and availability of funds drive the growth of the market. Moreover, increasing government support for research & development, changing lifestyle, and rapid development in technology will fuel the market growth during the forecast period. On the other hand, higher cost of the treatment procedure may slow the market growth during the review period.
Request Sample Copy:
https://www.marketresearchfuture.com/sample_request/5092
Over the last decade, the number of hospitals has increased to a great extent, which has influenced the growth of the market positively. Moreover, increasing demand for better treatment and changing reimbursement policies have fueled the market growth.
The global arteriovenous malformation market is expected to grow at a CAGR of ~6.1% during the forecast period 2017-2023.
Regional Analysis
The Americas dominate the global arteriovenous malformation market owing to the presence of huge patient population, high health care spending, and increasing government support for research & development.
Europe holds the second largest share of the global market. The increasing focus of various government agencies on treating various brain disorders or brain injuries such as epilepsy and depression will have a positive impact on the growth of the market. The growing public awareness will boost the adoption of these devices in the European market.
Asia Pacific is the fastest growing arteriovenous malformation market across the globe. Japan holds a major share of the regional market due to availability of technology and huge healthcare spending. Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.
Segmentation
The global arteriovenous malformation market is segmented on the basis of types, diagnosis, treatment, and end user. On the basis of types, it is segmented into true arteriovenous malformation, occult or cryptic AVM or cavernous malformations, venous malformation, hemangioma, and dural fistula. On the basis of diagnosis, it is segmented into physical examination, blood test, brain scans, and others. Brain scan is further segmented into computerized tomography (CT) scan, Magnetic Resonance Imaging (MRI), magnetic resonance angiography (MRA), and electroencephalography (EEG). On the basis of treatment, the market is segmented into endovascular embolization, neurosurgery and others. On the basis of the end user, it is segmented into hospitals & clinics, research laboratories and others.
Key Players
Some of key the players in the market are Toshiba Medical Systems Corporation (Japan), Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan), Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
Browse Full Report @
https://www.marketresearchfuture.com/reports/arteriovenous-malformation-market-5092
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Cerebral haemorrhage refers to uncontrolled bleeding in the brain.
Change in level of consciousness or alertness.
Paralysis or inability to move a particular body part.
Not all people with risk factors will get cerebral haemorrhage.
Arteriovenous malformations caused due to abnormal connections between veins and arteries.
Cerebral aneurysms which refer to the life-threatening weakening and bulging of the artery walls that can burst and lead to severe brain haemorrhage.
A craniotomy is a neurosurgical procedure, in which a part of the bone is removed from the skull exposing the brain.
This technique is majorly used before the brain surgery to treat brain tumours, arteriovenous malformation (AVM), blood clots and swelling in the brain, skull fractures and infection.
Contact us for more Information about Craniotomy Surgery in India.
Market Highlights:Chiari Malformation is structural defects in which brain tissue extends into the spinal canal.
Global Chiari Malformation treatment Market type is expected to grow at a CAGR of 8.2% during the forecast period.SegmentationThe global Chiari malformations infection market is segmented on the basis of type, treatment, diagnosis, and end-users.On the basis of the type, the market is segmented type I, type II, type III, type IV.By treatment, the market is segmented into Medications and Surgery.
Surgery is further sub-segmented into Posterior fossa decompression, Electrocautery, and Spinal laminectomy.On the basis of diagnosis, the market is segmented into X-Ray, CT Scan, and MRI.On the basis of end user the market is segmented into Hospitals & Surgical Centres, Research Institutes, and Specialty clinics.Regional Analysis:The Americas dominate the global Chiari Malformation market owing to the rising geriatric population, increase in genetic disorders and increasing number of injuries leading to infections.
North America holds the largest market owing to extensive use of advanced technology and developed pharmaceutical sector.Europe accounts for the second largest market due to increasing funds and increasing healthcare expenditure.
Germany, France, and the U.K hold a significant share in the market due to increasing demand for technologically advanced devices and increasing awareness in terms of rare diseases and rising overall growth of medical device industry.The Asia Pacific is the fastest growing market for the Chiari Malformation, whose growth is attributed to rising geriatric population, the increasing prevalence of people suffering from injuries, and rapidly developing economies.
For instance, according to ESCAPE (Economic and Social Commission for Asia and the Pacific), in the year 2016, approximately 12.4% of the population was 60 years or older and is projected to increase to 1.3 billion people by 2050.
Market HighlightsDural arteriovenous fistula is an abnormal connection between an artery and a vein.
Any organ of the body can suffer from fistula.
The brain is bounded by a tough fibrous cover called dura mater or dura.
Mostly migraine occurs at the age of 25-55.Request Sample Copy:https://www.marketresearchfuture.com/sample_request/4589Increasing prevalence of neurological disorder such as epilepsy and migraine leads to dural arteriovenous fistulae and increasing investment in biotechnology and pharmaceutical industries in R drive the growth of the market.
Moreover, increasing government support for research & development, changing lifestyle, and rapidly developing technology projected to fuel the market growth during the forecast period.
The increasing focus of various government agencies on treating epilepsy, depression, and heart attacks expected to have a positive impact on the growth of the market over the assessment period.
